Table 2.

Comparison of treatment interruptions in naive and experienced patients receiving a rilpivirine-based cART

	Naive		Experienced		p-value
	Number	%	Number	%
No	127	92.0	291	80.6
Yes	11	8.0	70	19.4	0.002
Reason for interruption
Death	0	0	2	2.9
Virological failure	1	9.1	7	10.0
Adverse events	4	36.4	32	45.7
Grade 1–2	2		18
Grade 3–4	2		14
Lost at follow-up	2	18.2	15	21.4
Other	4	36.4	14	20.0	0.79

Abbreviation: cART, combination antiretroviral therapy.